4/A

OWNERSHIP DOCUMENT

Company: SUPERNUS PHARMACEUTICALS, INC.
Filed: February 25, 2022
Period of Report: February 22, 2022
Accession Number: 0001104659-22-027394

View Document ↗ View on SEC.gov ↗